Basit öğe kaydını göster

dc.contributor.authorErbaş, Oytun
dc.contributor.authorYılmaz, Mustafa
dc.contributor.authorKorkmaz, Hüseyin Anıl
dc.contributor.authorBora, Saylav
dc.contributor.authorEvren, Vedat
dc.contributor.authorPeker, Gönül
dc.date.accessioned2020-11-20T16:20:10Z
dc.date.available2020-11-20T16:20:10Z
dc.date.issued2013
dc.identifier.issn0196-9781
dc.identifier.issn1873-5169
dc.identifier.urihttps://doi.org/10.1016/j.peptides.2012.12.003
dc.identifier.urihttps://hdl.handle.net/20.500.12809/3862
dc.descriptionWOS: 000319635500021en_US
dc.descriptionPubMed ID: 23246528en_US
dc.description.abstractWe aimed to reveal the anti-convulsant effects of oxytocin (OT) in pentylenetetrazol (PTZ)-induced seizures in rats. Thirty rats were randomly divided into 5 equal groups. Using stereotaxy, we implanted electroencephologram (EEG) electrodes in the left nucleus of the posterior thalamus. After 2 days, the first and second groups were used as the control and PTZ (35 mg/kg) groups, respectively. We administered 40, 80 and 160 nmol/kg OT + 35 mg/kg PTZ to the rats, constituting the third, fourth, and fifth groups, respectively, for 5 days. At the end of 5 days, we recorded EEGs via bipolar EEG electrodes. After 12 h, all groups except the first received 70 mg/kg PTZ and we determined the dose-response ratio. Racine's Convulsion Scale was used to evaluate seizures. The spike-wave complex percentage in the EEG was determined as 0% for the first group, 38.6%+/- 7.2 for the second group, 36.4%+/- 5.6 for the third group, 4.3%+/- 1.8 for the fifth group and 4.1%+/- 1.1 for the fifth group. The fourth and fifth groups had significantly decreased spike-wave complex percentages compared to the second group (p<0.0001). OT may prevent PTZ-induced epilepsy on an EEG. OT may also be considered for use in the treatment of epilepsy in the future. (C) 2012 Elsevier Inc. All rights reserved.en_US
dc.item-language.isoengen_US
dc.publisherElsevier Science Incen_US
dc.item-rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectOxytocinen_US
dc.subjectPentylenetetrazolen_US
dc.subjectEpilepsyen_US
dc.subjectRaten_US
dc.titleOxytocin inhibits pentylentetrazol-induced seizures in the raten_US
dc.item-typearticleen_US
dc.contributor.departmentMÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.contributor.institutionauthorYılmaz, Mustafa
dc.identifier.doi10.1016/j.peptides.2012.12.003
dc.identifier.volume40en_US
dc.identifier.startpage141en_US
dc.identifier.endpage144en_US
dc.relation.journalPeptidesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster